Literature DB >> 21525852

Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract.

John D Spencer1, Andrew L Schwaderer, Julianne D Dirosario, Kirk M McHugh, Glen McGillivary, Sheryl S Justice, Ashley R Carpenter, Peter B Baker, Jürgen Harder, David S Hains.   

Abstract

Although the urinary tract is constantly challenged by microbial invasion, it remains free from colonization. Although little is known about how the urinary tract maintains sterility, the presence of antimicrobial peptides (AMPs) in the urine suggests that they may play a role in its protection from infection. Ribonuclease 7 (RNase 7) is a potent AMP that was first identified in the skin. Here, we characterize the expression and relevance of RNase 7 in the human kidney and urinary tract. Using RNA isolated from healthy human tissue, we performed quantitative real-time PCR and found basal RNASE7 expression in kidney and bladder tissue. Immunohistochemical and immunofluorescent analysis localized RNase 7 to the urothelium of the bladder, ureter, and the intercalated cells of the collecting tubules. In control urine samples from healthy individuals, the concentration of RNase 7 was found to be in the low micromolar range; very abundant for an AMP. Antibacterial neutralization assays showed that urinary RNase 7 has potent antimicrobial properties against Gram-negative and Gram-positive uropathogenic bacteria. Thus, RNase 7 is expressed in the human kidney and urinary tract and it may have an important antimicrobial role in maintaining tract sterility.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525852     DOI: 10.1038/ki.2011.109

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  61 in total

Review 1.  Collecting duct intercalated cell function and regulation.

Authors:  Ankita Roy; Mohammad M Al-bataineh; Núria M Pastor-Soler
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-28       Impact factor: 8.237

Review 2.  Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.

Authors:  Brian Becknell; Andrew Schwaderer; David S Hains; John David Spencer
Journal:  Nat Rev Nephrol       Date:  2015-07-07       Impact factor: 28.314

Review 3.  The therapeutic applications of antimicrobial peptides (AMPs): a patent review.

Authors:  Hee-Kyoung Kang; Cheolmin Kim; Chang Ho Seo; Yoonkyung Park
Journal:  J Microbiol       Date:  2016-12-30       Impact factor: 3.422

4.  Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract.

Authors:  Tad E Eichler; Brian Becknell; Robert S Easterling; Susan E Ingraham; Daniel M Cohen; Andrew L Schwaderer; David S Hains; Birong Li; Ariel Cohen; Jackie Metheny; Susheela Tridandapani; John David Spencer
Journal:  Kidney Int       Date:  2016-07-09       Impact factor: 10.612

Review 5.  The role of the antimicrobial peptide cathelicidin in renal diseases.

Authors:  Milan Chromek
Journal:  Pediatr Nephrol       Date:  2014-08-27       Impact factor: 3.714

6.  Kidney α-intercalated cells and lipocalin 2: defending the urinary tract.

Authors:  Yuxuan Miao; Soman N Abraham
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

7.  Urinary defense begins in the kidney.

Authors:  Tian Shen; Abraham Levitman; Yuanji Li; Mendel Jacobs; Katherine Xu; Jonathan Barasch
Journal:  Kidney Int       Date:  2019-09       Impact factor: 10.612

Review 8.  The nature of immune responses to urinary tract infections.

Authors:  Soman N Abraham; Yuxuan Miao
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

9.  α-Intercalated cells defend the urinary system from bacterial infection.

Authors:  Neal Paragas; Ritwij Kulkarni; Max Werth; Kai M Schmidt-Ott; Catherine Forster; Rong Deng; Qingyin Zhang; Eugenia Singer; Alexander D Klose; Tian Huai Shen; Kevin P Francis; Sunetra Ray; Soundarapandian Vijayakumar; Samuel Seward; Mary E Bovino; Katherine Xu; Yared Takabe; Fábio E Amaral; Sumit Mohan; Rebecca Wax; Kaitlyn Corbin; Simone Sanna-Cherchi; Kiyoshi Mori; Lynne Johnson; Thomas Nickolas; Vivette D'Agati; Chyuan-Sheng Lin; Andong Qiu; Qais Al-Awqati; Adam J Ratner; Jonathan Barasch
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

10.  Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.

Authors:  David Pulido; Marc Torrent; David Andreu; M Victoria Nogués; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.